# Haploidentical NK Cell Infusion in Malignant Melanoma

> **NCT00846833** · PHASE1,PHASE2 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 12 (estimated)

## Conditions studied

- Melanoma

## Interventions

- **BIOLOGICAL:** Haploidentical NK cell

## Key facts

- **NCT ID:** NCT00846833
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2011-02
- **Final completion:** 2012-04
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2012-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00846833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00846833, "Haploidentical NK Cell Infusion in Malignant Melanoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00846833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*